FCMV
CGON icon

Foresite Capital Management VI’s CG Oncology CGON Stock Holding History

Foresite Capital Management VI’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$168M Buy
2,369,574
+148,100
+7% +$9.68M 26.2% 1
2026
Q1 		$150M Hold
2,221,474
– – 32.67% 1
2025
Q4 		$92.2M Hold
2,221,474
– – 27.88% 1
2025
Q3 		$89.5M Hold
2,221,474
– – 34.57% 1
2025
Q2 		$57.8M Hold
2,221,474
– – 32.47% 1
2025
Q1 		$54.4M Hold
2,221,474
– – 29.8% 1
2024
Q4 		$63.7M Buy
+2,221,474
New +$76M 28.39% 1

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Foresite Capital Management VI's CGON Position: Q2 2026 in Review

Foresite Capital Management VI increased its CG Oncology (CGON) stake by 6.7% in Q2 2026, buying an estimated $9.68M and bringing the position to 2,369,574 shares worth $168M. The position accounts for 26.2% of the portfolio, ranked #1.

Foresite Capital Management VI first reported a position in CGON in Q4 2024 and has held it in 7 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Foresite Capital Management VI held 2,369,574 shares of CG Oncology worth $168M as of Q2 2026.
  • Foresite Capital Management VI bought 148,100 CG Oncology shares in Q2 2026, an estimated $9.68M.
  • CG Oncology made up 26.2% of Foresite Capital Management VI's portfolio in Q2 2026, its #1 holding.
  • Foresite Capital Management VI first reported a position in CG Oncology in Q4 2024 and has held it in 7 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Foresite Capital Management VI's 13F filing for Q2 2026, filed 14 Aug 2026.